Slightly Higher Times: Biden Administration Moves To Loosen Weed Restrictions

The Biden administration’s Department of Health and Human Services is recommending that the Drug Enforcement Administration significantly loosen federal restrictions on marijuana but stopped short of advising that it should be entirely removed from the Controlled Substances Act.

Read More

California Pharmacies Are Making Millions Of Mistakes. They’re Fighting To Keep That Secret

California pharmacies, including those owned by big chains, make an estimated 5 million errors a year — but they’re not required to report them to state regulators.

Read More

Pharmaceutical Industry Rips ‘Draconian’ Price Negotiation Provision

The Biden administration and federal regulators may be taking a victory lap following the unveiling of the Centers for Medicare & Medicaid Services’ (CMS’) price negotiations list, but major players in the pharmaceutical industry feel the White House overstepped and think innovation will be stifled, ultimately leading to the creation of fewer life-changing drugs. Tuesday, CMS ...

Read More

Biden Administration Expects To Win Fight Over Medicare Drug Negotiations

White House domestic policy adviser Neera Tanden said Sunday that she’s convinced that the Inflation Reduction Act’s Medicare drug price negotiation program will be upheld in court. Speaking on “The Katie Phang Show” on MSNBC, Tanden said, “There is nothing in the Constitution that stops Medicare from negotiating drug prices. We really, we feel very ...

Read More

Humana Sues Feds Over Medicare Advantage Risk Adjustment Changes

Humana has filed suit against the feds, saying the Biden administration’s bid to claw back overpayments in Medicare Advantage (MA) is built on “shifting justifications and erroneous legal reasoning.” Earlier this year, the Centers for Medicare & Medicaid Services (CMS) finalized a hotly anticipated rule that would overhaul risk adjustment data validation (RADV) audits, which determine whether ...

Read More

US Lab Tests Suggest New COVID-19 Variant BA.2.86 May Be Less Contagious And Less Immune-Evasive Than Feared

Two teams of US scientists have completed lab experiments testing the antibodies from vaccinated and infected Americans to see how well they might be able to fend off currently circulating variants of the virus that causes Covid-19, including the highly mutated BA.2.86. Their results match up almost exactly, and the news – at least when ...

Read More

Jimmy Buffett Died of Rare Form of Skin Cancer

Jimmy Buffett died of skin cancer at his home in Sag Harbor, N.Y., on Long Island, according to a statement on the singer-songwriter’s website. After Mr. Buffett died on Friday at age 76, his site announced the death but did not give a cause or specify where he died. In an update over the weekend, the website said that ...

Read More

How We Age—and How Scientists Are Working to Turn Back the Clock

Scientists obsessed with aging are sketching a road map of how our bodies change as we grow old in the hopes that it will lead to treatments that could help us live longer, healthier lives. They call this road map the “hallmarks of aging”—a set of biological features and mechanisms linked to our inexorable march ...

Read More

What Impact Will California’s New “Transaction Review” Law Have?

California passed a law last year aimed at controlling rising healthcare costs that gave the state the ability to scrutinize healthcare deals of a certain size involving California companies. What impact can it have?

Read More

Biden Administration Unveils First 10 Drugs Subject To Medicare Price Negotiations

The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square